Proteinuria Induced by Parenteral Iron in Chronic Kidney Disease—A Comparative Randomized Controlled Trial

Por Agarwal, Rajiv, Leehey, David J., Olsen, Scott M., Dahl, Naomi V.
Publicado em 2011

Ferumoxytol versus iron sucrose treatment: a post-hoc analysis of randomized controlled trials in patients with varying renal function and iron deficiency anemia

Por Strauss, William E., Dahl, Naomi V., Li, Zhu, Lau, Gloria, Allen, Lee F.
Publicado no BMC Hematol (2016)

Efficacy and safety of IV ferumoxytol for iron deficiency anemia in patients with cancer

Por Vadhan-Raj, Saroj, Dahl, Naomi V, Bernard, Kristine, Li, Zhu, Strauss, William E
Publicado no J Blood Med (2017)

Cost-effectiveness analysis of intravenous ferumoxytol for the treatment of iron deficiency anemia in adult patients with non-dialysis-dependent chronic kidney disease in the USA

Por Dahl, Naomi V, Kaper, Robert F, Strauss, William E, Corvino, Frank A, Zivkovic, Marko
Publicado no Clinicoecon Outcomes Res (2017)

The Ferumoxytol for Anemia of CKD Trial (FACT)—a randomized controlled trial of repeated doses of ferumoxytol or iron sucrose in patients on hemodialysis: background and rationale...

Por Macdougall, Iain C., Dahl, Naomi V., Bernard, Kristine, Li, Zhu, Batyky, Alka, Strauss, William E.
Publicado no BMC Nephrol (2017)

Correction to: The Ferumoxytol for Anemia of CKD Trial (FACT)—a randomized controlled trial of repeated doses of ferumoxytol or iron sucrose in patients on hemodialysis: background...

Por Macdougall, Iain C., Dahl, Naomi V., Bernard, Kristine, Li, Zhu, Batycky, Alka, Strauss, William E.
Publicado no BMC Nephrol (2018)

Safety and efficacy of ferumoxytol for the episodic treatment of iron deficiency anemia in patients with a history of unsatisfactory oral iron therapy: Results of a phase III, open...

Por Vadhan-Raj, Saroj, Ford, David C, Dahl, Naomi V, Bernard, Kristine, Li, Zhu, Allen, Lee F, Strauss, William E
Publicado no Am J Hematol (2016)

Ferumoxytol versus placebo in iron deficiency anemia: efficacy, safety, and quality of life in patients with gastrointestinal disorders

Por Ford, David C, Dahl, Naomi V, Strauss, William E, Barish, Charles F, Hetzel, David J, Bernard, Kristine, Li, Zhu, Allen, Lee F
Publicado no Clin Exp Gastroenterol (2016)

Ferric Gluconate Reduces Epoetin Requirements in Hemodialysis Patients with Elevated Ferritin

Por Kapoian, Toros, O'Mara, Neeta B., Singh, Ajay K., Moran, John, Rizkala, Adel R., Geronemus, Robert, Kopelman, Robert C., Dahl, Naomi V., Coyne, Daniel W.
Publicado em 2008